Changes in the Multiple Sclerosis Treatment Paradigm. What Do We Do Now and What Were We Doing Before?

BACKGROUND AND PURPOSE: The number of disease-modifying drugs (DMDs) available for treating relapsing-remitting multiple sclerosis is increasing. Numerous drugs have been approved since 2010 in South America, which has increased the complexity of the treatment algorithm. The aim of this study was to...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Neurol
Autors principals: Alonso, Ricardo, Eizaguirre, María Bárbara, Zavala, Lucía, Pita, Cecilia, Silva, Berenice, Garcea, Orlando
Format: Artigo
Idioma:Inglês
Publicat: Korean Neurological Association 2018
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6172498/
https://ncbi.nlm.nih.gov/pubmed/30198224
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3988/jcn.2018.14.4.487
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars